Dr. Bob Smouse has over 20 years of experience in interventional radiology, endovascular surgery and clinical research. In addition to acting as CEO and CMO of BrightWater Medical and teaching at the University of Illinois College of Medicine, he provides interventional medical services to local hospitals through Central Illinois Radiology Associates. Dr. Smouse is a...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To 

More than a decade ago, AUM Cardiovascular founder Dr. Marie Johnson was a doctoral student when tragedy struck her and her family. Her husband, Rob, passed away suddenly at the age of 41. He had blockages in his coronary arteries including a ruptured plaque in the left anterior descending artery supplying a large part of...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To 

Shaun Bagai is the CEO of RenovoRx.  He has over 16 years of medtech experience across multiple functional areas like clinical research, sales, marketing, and market development. He was instrumental in developing the European market for renal denervation, which led to the acquisition of the first renal denervation company, Ardian, by Medtronic in 2011. Most...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To 

Bill Facteau joined Earlens Corporation as Chairman, President, and CEO in November of 2013. Most recently, he was the Vice Chairman of ExploraMed, a medical device incubator based on the West Coast and an Entrepreneur in Residence at New Enterprise Associates. Previously, Bill was at Johnson & Johnson from early 2010 through early 2012 as...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To 

Dr. John Simpson.  Even if you’re a medical device newbie, you’ve probably heard of him.  He’s credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA).  This single idea created the field of interventional cardiology as we know it today. Over the course of his renowned medtech career...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To 

Biz Stone, the co-founder of Twitter, has famously stated, “Timing, perseverance, and 10 years of trying will eventually make you look like an overnight success.”   In the world of medtech startups, this is almost always the case.  And it’s certainly true with UroLift, a device that came to life in the fall of 2004...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• How Will These 2 Major Healthcare Changes Affect Medical Device Companies? 

Engaging with patients in a genuine and transparent way is tough.  Really tough.  It’s challenging for all healthcare stakeholders – payers, providers, and industry. From a medtech perspective, we often times get stuck in a certain mindset when trying to engage with patients. Whether it’s a continuous glucose monitor for diabetic patients or a new...[read more]

Related Stories

• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To
• Social Media Best Practices for Marketing Medical Devices
• Are Medical Device Models the Key to Building a Lean Medtech Startup? 

CMS has an objective to shift 50% of all reimbursement services from fee-for-service to alternative, value-based methods by 2018.  And bundled payment models, according to Dr. Dan Mazanec, will be the principal driver of this transformative initiative. But the topic of value-based healthcare can be pretty confusing , right?  Comprehensive Care for Joint Replacement.  Medicare Access...[read more]

Related Stories

• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To
• Social Media Best Practices for Marketing Medical Devices
• Are Medical Device Models the Key to Building a Lean Medtech Startup? 

For as long as I can remember, at every company meeting I’ve ever been to, the topic of off-label promotion is always covered.  Whether it was new-hire orientation, a national sales meeting, or some other large commercial event, the dissemination of off-label information was always presented as not only a fireable offense, but something that could get you...[read more]

Related Stories

• How Will These 2 Major Healthcare Changes Affect Medical Device Companies?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To
• Social Media Best Practices for Marketing Medical Devices 

Jack Dorsey received quite a bit of attention when he was recently announced as CEO of Twitter.  Why?  Because that made him CEO of 2 of the most rapidly-growing tech. companies in Silicon Valley at the same – Twitter and Square. Well, medtech’s version of Jack Dorsey might be Duke Rohlen.  Duke led FoxHollow Technologies...[read more]

Related Stories

• Why Intersect ENT is an Example of Hope for the Medtech Industry
• Are Medical Device Models the Key to Building a Lean Medtech Startup?
• Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To